Loading clinical trials...
Loading clinical trials...
Background: The optimal treatment of anaplastic gliomas is controversial. Standard of care in most centers is still radiotherapy. This phase III study compared the efficacy and safety of radiotherapy ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Neuro-Oncology Working Group of the German Cancer Society
Collaborators
NCT01269853 · Glioblastoma Multiforme, Anaplastic Astrocytoma
NCT02800486 · Glioblastoma, Anaplastic Astrocytoma, and more
NCT05839379 · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, and more
NCT04702581 · Oligodendroglioma, Low-grade Oligodendroglioma, and more
NCT05084430 · Glioblastoma Multiforme, Anaplastic Astrocytoma, and more
University of Heidelberg
Heidelberg, Baden-Wurttemberg
Neurology and Radiotherapy
Tübingen, Baden-Wurttemberg
Klinikum Aschaffenburg
Aschaffenburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions